Serge Bromberg

Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.

Oxus Holding SA provides administrative and management services, with interest in financial investment activities for small and medium enterprises. The company was founded in 2007 and is headquartered in Luxembourg.

Genosafe SAS specializes in evaluating the quality, safety, and efficacy of innovative biological products. Its services are discovery research, preclinical development, quality control (QC) testing, clinical development, analytical development, and regulatory affairs. The company was founded in 2003 and is headquartered in Evry, France.

Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021.